about
Local transplantation of granulocyte colony-stimulating factor-mobilized human peripheral blood mononuclear cells for unhealing bone fractures.Neuron-like differentiation of bone marrow-derived mesenchymal stem cells.Uric acid promotes neuronal differentiation of human placenta-derived mesenchymal stem cells in a time- and concentration-dependent manner.Amyotrophic lateral sclerosis: update for family physiciansMotor neuron degeneration promotes neural progenitor cell proliferation, migration, and neurogenesis in the spinal cords of amyotrophic lateral sclerosis mice.Host induction by transplanted neural stem cells in the spinal cord: further evidence for an adult spinal cord neurogenic niche.Differentiation of CD133+ stem cells from amyotrophic lateral sclerosis patients into preneuron cellsGood practice in the management of amyotrophic lateral sclerosis: clinical guidelines. An evidence-based review with good practice points. EALSC Working Group.Current clinical trials in amyotrophic lateral sclerosis.The use of stem cells for the treatment of autoimmune diseases.Genetic modification of human embryonic stem cells.Functional analysis of various promoters in lentiviral vectors at different stages of in vitro differentiation of mouse embryonic stem cells.Mesenchymal stem cells promote proliferation of endogenous neural stem cells and survival of newborn cells in a rat stroke model.Amyotrophic lateral sclerosis (ALS): three letters that change the people's life. For ever.Amyotrophic lateral sclerosis: applications of stem cells - an update.Mesenchymal stem cell therapy for the treatment of amyotrophic lateral sclerosis: signals for hope?Adult olfactory bulb neural precursor cell grafts provide temporary protection from motor neuron degeneration, improve motor function, and extend survival in amyotrophic lateral sclerosis mice.Cultivating stem cells for treating amyotrophic lateral sclerosis.Comparative effects between bone marrow and mesenchymal stem cell transplantation in GDNF expression and motor function recovery in a motorneuron degenerative mouse model.Unintended changes in cognition, mood, and behavior arising from cell-based interventions for neurological conditions: ethical challenges.Direct comparison of progenitor cells derived from adipose, muscle, and bone marrow from wild-type or craniosynostotic rabbits.Alteration in genes expression patterns during in vitro differentiation of mouse spermatogonial cells into neuroepithelial-like cells.Safety and seizure control in patients with mesial temporal lobe epilepsy treated with regional superselective intra-arterial injection of autologous bone marrow mononuclear cells.Behavioral and histological characterization of intrahippocampal grafts of human bone marrow-derived multipotent progenitor cells in neonatal rats with hypoxic-ischemic injury.Transplantation of cryopreserved human bone marrow-derived multipotent adult progenitor cells for neonatal hypoxic-ischemic injury: targeting the hippocampus.Comparison of the growth hormone, IGF-1 and insulin in cerebrospinal fluid and serum between patients with motor neuron disease and healthy controls.Towards personalized cell-replacement therapies for brain repair.Stem cell transplantation in amyotrophic lateral sclerosis patients: methodological approach, safety, and feasibility
P2860
Q34022441-CC2B1269-9754-4C38-8163-9EB93BE772D0Q35003377-A79E77AF-4D0D-44E9-897E-3F84AF476F0AQ35134949-19B00B58-BD4A-4FFB-93AF-A1ACBE1B72A3Q35613311-A7C6C03C-5594-4FF8-AD4D-AB73F1B89FE3Q35688106-26C9486B-7BDF-46AF-ABA6-E26BA5B7884BQ36570398-4D6F3471-52BF-409F-8578-725BDF0FD036Q36861763-FB084729-BB5C-4C87-9BA5-08026642E755Q36892306-4EABE36A-9F03-448D-BCA0-AE291DB24A05Q36904850-4183AC52-00B1-47DB-BF6C-0ED9FE161F04Q36916687-957858F2-F0DA-4A95-AB74-7861A6E211B7Q37024721-70B13609-092B-4D88-808E-A8BA16FFC33CQ37037834-4AF27717-2546-4B6B-AB97-8B283390CDD8Q37184838-D18C36AD-9B19-4E3E-B1F5-0A276978ABD4Q37590212-2ABCB5B9-A80A-4A54-8F44-2DC6B18EA7D5Q38160459-A9C03825-A6B3-4E06-B48C-6639199DB8FBQ38265205-6660B5B5-9995-44B3-9419-0D19C44ED78EQ38296647-53EC9A04-BD1A-4AE1-8FA0-EBD566479110Q39447645-F1BDCFC0-C429-44D9-82EA-336B25C046EBQ39515636-E00A5F84-354C-4CD3-8F82-3EC6F2D00F00Q39984564-22DC356B-4B6F-4AE6-B4A1-339E6B0B1E55Q41612445-43CB267F-16AC-4028-A008-353C694FB267Q42532648-4BD7B208-0501-4715-A0F2-9EF8DF76755FQ48491687-65C2D572-7195-44E9-A1BD-F8BCA59F4184Q48526496-74959965-2858-4053-A9D6-313C5C591DFEQ48537626-BCE42B3D-55FC-479B-92D4-ACC9CF7BD8B6Q53816251-66BECDA7-C682-47F6-982A-BB3CE7195724Q54035553-1A049BDF-966A-42CA-8B4F-863C88C11698Q56775496-C5CB2DF8-4FAA-43B2-99E1-3B7BF85343A7
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Stem-cell therapy for amyotrophic lateral sclerosis.
@ast
Stem-cell therapy for amyotrophic lateral sclerosis.
@en
type
label
Stem-cell therapy for amyotrophic lateral sclerosis.
@ast
Stem-cell therapy for amyotrophic lateral sclerosis.
@en
prefLabel
Stem-cell therapy for amyotrophic lateral sclerosis.
@ast
Stem-cell therapy for amyotrophic lateral sclerosis.
@en
P2093
P1433
P1476
Stem-cell therapy for amyotrophic lateral sclerosis.
@en
P2093
Andrea Ciammola
Elio Polli
Lidia Cova
Massimo Corbo
Vincenzo Silani
P304
P356
10.1016/S0140-6736(04)16634-8
P407
P577
2004-07-01T00:00:00Z